Luxembourg

In another significant strategic move, GSK Stockmann welcomes Simon Spangler as a new partner as of 1 August 2025. This new addition underlines the firm’s leading position in commercial law and transformation issues and will enhance its range of advisory expertise for national and international clients and projects. Dr Simon Spangler is a renowned expert in German and European antitrust law as well as in the areas of compliance and ESG. He specialises in providing antitrust and distribution law advice to companies in the technology, consumer goods and life sciences sectors. He also provides comprehensive advice on issues relating to the platform economy, private enforcement issues and merger control proceedings at the national and international level. In addition, he has many years of experience in related compliance issues, particularly in ESG compliance and internal investigations, as well as in state aid and subsidy law. Simon Spangler’s wealth of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s Corporate team, where he will work closely with the firm’s IT and AI specialists to set new benchmarks in the field of digital economy and AI solutions and help to accelerate the firm’s growth. Simon Spangler is joining GSK Stockmann from Oppenhoff & Partner, where he has worked in the field of antitrust and state aid law since 2013, becoming a partner in January 2019. He will be accompanied by his colleague Renée Eckruth, who will join GSK Stockmann as a Senior Associate. “We are delighted to be welcoming a recognised expert like Simon Spangler to our team. His expertise and network will be a great asset and support the strategic development of our Corporate team. The addition of this new team ensures that we are now in an even stronger position to continue providing our clients with the best possible support with all kinds of complex matters in the future,” says Dr Justus Jansen, Managing Partner at GSK Stockmann. “Simon Spangler’s impressive range of expertise will be a valuable addition to our Corporate team in Germany, Luxembourg and London. Thanks to his extensive expertise in antitrust law and compliance advice, we can now offer the full scope of services in this area. This enables us to provide real added value to our clients and explore additional areas of advice with significant business development potential. His knowledge and many years of experience will help to strengthen and enhance our Corporate team in the long term,” comments Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division. Simon Spangler also sees great potential in his new role at GSK Stockmann: “I am very pleased to be able to put my expertise to good use at GSK Stockmann – especially in dynamic, future-oriented fields such as digitalisation and ESG. Together with the experienced team at GSK Stockmann, I am confident that I can provide our clients with bespoke, forward-thinking advice.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

Commercial law firm GSK Stockmann continues the strategic expansion of its Corporate team by welcoming Bernd Graßl as a partner at its Munich office with effect from 1 August 2025. The new addition highlights the firm’s leading position in European commercial law and will enhance its range of advisory expertise for listed companies and international cases, as well as in corporate litigation. Dr Bernd Graßl, formerly a partner at GLNS, has extensive expertise in stock corporation and capital markets law, public M&A and corporate law as well as in stock corporation and capital markets disputes and corporate litigation. His many years of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s growing Corporate team. As a trusted expert in his field, Bernd Graßl will help to further strengthen the firm’s 360-degree advisory approach. This means that clients will benefit from even more comprehensive, customised solutions both in Germany and at GSK Stockmann’s international offices in Luxembourg and London. Bernd Graßl will bring fresh dynamism to the team, particularly when it comes to supporting capital market companies and advising on complex corporate law issues and the particularities of legal disputes involving listed companies. “With Bernd Graßl on board, we are ideally positioned to advise and represent clients in the currently recovering stock market environment. His broad expertise and experience are a valuable addition to our Corporate team, both throughout Germany and internationally,” says Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division, commenting on the arrival of the new partner. “His proven track record in stock corporation and capital markets law, as well as in IPOs for tech companies, makes him a real asset for our clients and our team. The firm will also benefit greatly from his experience in corporate litigation.” “Bernd Graßl’s expertise will enable us to provide our clients with even more comprehensive and strategic support in complex corporate law disputes,” adds Dr Justus Jansen, Managing Partner at GSK Stockmann. “His expertise complements our existing knowledge perfectly and will help us to continue to strengthen our position in the area of corporate litigation. This will allow us to offer our clients an even broader spectrum of high-quality advice – both here in Germany and internationally.” Bernd Graßl is looking forward to his new role: “GSK Stockmann stands for legal advice of the highest quality, entrepreneurial foresight and a strong international network. I am looking forward to working with a highly motivated team to develop innovative, bespoke solutions for our clients, as well as expanding the firm’s range of services throughout Europe.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised DZ HYP AG on the financing of the Upper West high-rise building in Berlin-Charlottenburg. The buyer is Schoeller Group GmbH, based in Pullach near Munich. Upper West is located directly on Berlin’s Breitscheidplatz, opposite Kaiser Wilhelm Memorial Church and just a stone’s throw from the city’s famous shopping boulevard, Kurfürstendamm. At around 120 metres high, it is one of the tallest buildings in Berlin. The building’s distinctive glass and steel façade makes it a striking part of the city’s skyline. The building also meets high standards in terms of urban development and sustainability. Upper West combines office and retail space, as well as a Motel One flagship hotel with 582 rooms over 19 floors. The building is DGNB Gold & LEED Platinum certified. A GSK Stockmann team led by Munich partner Alma Franke advised DZ HYP on financing the purchase transaction. Advisers of DZ HYP AG at GSK Stockmann: Dr Alma Franke (lead), Dr Mechtild-Maria Siebke, Marcel Buss, Beatrice Christina Dörr (all finance), Robert Korndörfer, Dr Raoul Kreide, Matti Kamer (both corporate), Stefan Schlapka (real estate law/hospitality), Andreas Heinzmann, Hawa Mahamoud, Eva Jean (corporate/finance, Luxembourg)

Labour and social security law expert Daniel Nerl has joined GSK Stockmann’s team in Luxembourg as local partner, where he will develop the firm’s new practice in that area. He joins from leading independent business and litigation law firm Kleyr Grasso – together with his Associate Julie Tisserand – and will work closely together with Counsel Marie-Therese Wich. Daniel Nerl has extensive experience in the fields of labour and social security matters. He has been advising clients since 2011 on the entire spectrum of human resources matters by offering a full-service approach from advisory on day-to-day matters (including on- and offboarding, due diligences, general corporate support, etc.) to litigation. In addition, he has been a lecturer for training organisms on HR matters for over 10 years. Daniel Nerl studied in France in Bordeaux and Paris at the Sorbonne and was admitted to the bar in Luxembourg in 2011; he is member of ELSA asbl – Employment Law Specialist Association Luxembourg. “We are pleased to welcome Daniel Nerl and Julie Tisserand to our team. Their strong experience in the field of labour law and litigation as well as their deep expertise of the Luxembourg market will benefit our international client base”, comments Andreas Heinzmann, Partner at GSK Stockmann in Luxembourg. “We are looking forward to working with the new team members who will further strengthen our international capabilities in labour law and litigation. We wish them a great start at GSK Stockmann”, adds Dr. Oliver Glück, Co-Managing Partner at GSK Stockmann. “I am thrilled to join GSK Stockmann in Luxembourg, together with my long-term colleague Julie Tisserand, and am looking forward to working with a strong team on challenging and complex projects”, says Daniel Nerl. The office of GSK Stockmann in Luxembourg opened in 2016 with four partners and has since grown to a team of more than 30 fee earners focussing on the field of Banking & Finance, Capital Markets, Corporate and M&A, Private Equity, Investment Funds, Real Estate, Regulatory, Insurance, and Tax. Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de